No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs191828816 |
chr15:45402406-45402407 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs551788567 |
chr15:45402415-45402416 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs72724247 |
chr15:45402429-45402430 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs553745707 |
chr15:45402438-45402439 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs571969751 |
chr15:45402469-45402470 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs113324656 |
chr15:45402479-45402480 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs376092886 |
chr15:45402501-45402502 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs111708176 |
chr15:45402506-45402507 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs568023150 |
chr15:45402526-45402527 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs374084745 |
chr15:45402556-45402557 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs536890454 |
chr15:45402585-45402586 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs368195994 |
chr15:45402590-45402591 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs374919001 |
chr15:45402600-45402601 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs370752559 |
chr15:45402626-45402627 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs375264413 |
chr15:45402629-45402630 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs573609412 |
chr15:45402630-45402631 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs367829065 |
chr15:45402639-45402640 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs201416182 |
chr15:45402679-45402680 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs559264063 |
chr15:45402685-45402686 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs370110153 |
chr15:45402688-45402689 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs377608586 |
chr15:45402692-45402693 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs148754510 |
chr15:45402701-45402702 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs544236153 |
chr15:45402707-45402708 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs368909888 |
chr15:45402709-45402710 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs555083063 |
chr15:45402713-45402714 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs142354994 |
chr15:45402716-45402717 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs372682461 |
chr15:45402735-45402736 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs377197782 |
chr15:45402737-45402738 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs540065615 |
chr15:45402748-45402749 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs369596611 |
chr15:45402759-45402760 |
Bivalent Enhancer Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs372260934 |
chr15:45402805-45402806 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs201507902 |
chr15:45402816-45402817 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs370995201 |
chr15:45402821-45402822 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs79467028 |
chr15:45402830-45402831 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs373155740 |
chr15:45402836-45402837 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs545715198 |
chr15:45402838-45402839 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs562595411 |
chr15:45402850-45402851 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs376129290 |
chr15:45402859-45402860 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs200479757 |
chr15:45402880-45402881 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs151261408 |
chr15:45402883-45402884 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs568196384 |
chr15:45402888-45402889 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs140455650 |
chr15:45402893-45402894 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs527361236 |
chr15:45402898-45402899 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs144183694 |
chr15:45402903-45402904 |
Bivalent Enhancer Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs368847158 |
chr15:45402921-45402922 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs567090708 |
chr15:45402927-45402928 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs269859 |
chr15:45402940-45402941 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs386783603 |
chr15:45402951-45402952 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs201947197 |
chr15:45402953-45402954 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs148954300 |
chr15:45402957-45402958 |
Bivalent Enhancer Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|